Telix Pharmaceuticals Limited is a clinical-stage biotechnology company dedicated to the development and commercialisation of molecularly-targeted radiation (MTR) therapy. Our products seek to address major clinical unmet needs in the management of prostate, renal (kidney) and glioblastoma (brain) cancer.
Our mission is
to help patients
with cancer live longer
with better quality lives
@montypal for mentoring/powering me to #vailworkshop
@TelixPharma @asxlongtail for tlx250 trial that got me into #vail2019
Great clinical and research mentors @cityofhope including Dr. Caligiuri, Dr. Von Hoff, Dr Rosen, Dr Badie, Dr Bild, Dr Mortimer, Matt Loscalzo,